Halozyme Therapeutics shares owned by Neuberger Berman Group
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Neuberger Berman Group
from 13F filings
Historical chart of Neuberger Berman Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Neuberger Berman Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $1.8M | 27k | 67.30 |
| 2025-09-30 | $2.0M | 28k | 73.34 |
| 2025-06-30 | $9.5M | 183k | 52.02 |
| 2025-03-31 | $30M | 463k | 63.81 |
| 2024-12-31 | $18M | 376k | 47.81 |
| 2024-09-30 | $16M | 286k | 57.24 |
| 2024-06-30 | $15M | 277k | 52.36 |
| 2024-03-31 | $11M | 260k | 40.68 |
| 2023-12-31 | $6.5M | 177k | 36.96 |
| 2023-09-30 | $7.0M | 185k | 38.20 |
| 2023-06-30 | $6.6M | 183k | 36.07 |
| 2023-03-31 | $5.4M | 141k | 38.19 |
| 2022-12-31 | $7.6M | 134k | 56.90 |
| 2022-09-30 | $7.0M | 178k | 39.54 |
| 2022-06-30 | $7.7M | 175k | 44.00 |
| 2022-03-31 | $6.6M | 166k | 39.83 |
| 2021-12-31 | $6.4M | 159k | 40.17 |
| 2021-09-30 | $6.5M | 160k | 40.58 |
| 2021-06-30 | $11M | 231k | 45.35 |
| 2021-03-31 | $8.9M | 213k | 41.69 |
| 2020-12-31 | $6.4M | 149k | 42.71 |
| 2020-09-30 | $3.9M | 147k | 26.28 |
| 2020-06-30 | $3.0M | 113k | 26.81 |
| 2020-03-31 | $1.4M | 80k | 17.99 |
| 2017-12-31 | $810k | 40k | 20.25 |
| 2013-06-30 | $87k | 11k | 7.91 |